MEDP vs. DLB
MEDP (Medpace Holdings, Inc.) and DLB (Dolby Laboratories, Inc.) are both stocks. MEDP operates in Diagnostics & Research (Healthcare), while DLB operates in Information Technology Services (Technology). Over the past 5 years, MEDP returned 21.69%/yr vs -10.74%/yr for DLB. At a 0.38 correlation, their price movements are largely independent.
Performance
MEDP vs. DLB - Performance Comparison
Loading charts...
Returns By Period
The year-to-date returns for both stocks are quite close, with MEDP having a -16.79% return and DLB slightly lower at -17.26%.
MEDP
- 1D
- -1.63%
- 1M
- 10.28%
- YTD
- -16.79%
- 6M
- -16.23%
- 1Y
- 53.73%
- 3Y*
- 28.75%
- 5Y*
- 21.69%
- 10Y*
- —
DLB
- 1D
- -0.40%
- 1M
- -3.24%
- YTD
- -17.26%
- 6M
- -21.32%
- 1Y
- -28.66%
- 3Y*
- -13.16%
- 5Y*
- -10.74%
- 10Y*
- 2.40%
MEDP vs. DLB - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
MEDP Medpace Holdings, Inc. | -16.79% | 69.05% | 8.38% | 44.31% | -2.40% | 56.35% | 65.60% | 58.81% | 45.97% | 0.53% |
DLB Dolby Laboratories, Inc. | -17.26% | -16.27% | -7.95% | 23.82% | -24.90% | -0.99% | 42.99% | 12.63% | 0.78% | 38.73% |
Correlation
The correlation between MEDP and DLB is 0.29, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.29 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.32 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.39 |
Correlation (All Time) Calculated using the full available price history since Aug 11, 2016 | 0.38 |
The correlation between MEDP and DLB shifts across timeframes, from 0.29 (1 year) to 0.39 (5 years), reflecting how their relationship changes across market environments.
Fundamentals
MEDP:
$13.54B
DLB:
$5.02B
MEDP:
$15.63
DLB:
$2.53
MEDP:
29.89
DLB:
20.79
MEDP:
0.90
DLB:
30.68
MEDP:
5.14
DLB:
3.71
MEDP:
22.62
DLB:
1.92
MEDP:
$2.68B
DLB:
$1.36B
MEDP:
$778.59M
DLB:
$1.19B
MEDP:
$572.96M
DLB:
$347.35M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
MEDP vs. DLB — Risk / Return Rank
MEDP
DLB
MEDP vs. DLB - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Medpace Holdings, Inc. (MEDP) and Dolby Laboratories, Inc. (DLB). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| MEDP | DLB | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.93 | ||
| Sortino ratioReturn per unit of downside risk | +3.36 | ||
| Omega ratioGain probability vs. loss probability | 1.32 | 0.80 | +0.51 |
| Calmar ratioReturn relative to maximum drawdown | 1.48 | -0.96 | +2.43 |
| Martin ratioReturn relative to average drawdown | 3.28 | -1.93 | +5.21 |
Loading charts...
Drawdowns
MEDP vs. DLB - Drawdown Comparison
The maximum MEDP drawdown since its inception was -42.87%, smaller than the maximum DLB drawdown of -62.19%. Use the drawdown chart below to compare losses from any high point for MEDP and DLB.
Loading charts...
Drawdown Indicators
| MEDP | DLB | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -42.87% | -62.19% | +19.32% |
Max Drawdown (1Y)Largest decline over 1 year | -36.61% | -30.11% | -6.50% |
Max Drawdown (3Y)Largest decline over 3 years | -39.38% | -38.92% | -0.46% |
Max Drawdown (5Y)Largest decline over 5 years | -42.87% | -44.41% | +1.54% |
Max Drawdown (10Y)Largest decline over 10 years | — | -45.04% | — |
Current DrawdownCurrent decline from peak | -24.69% | -45.04% | +20.35% |
Average DrawdownAverage peak-to-trough decline | -12.92% | -22.37% | +9.45% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 16.45% | 14.84% | +1.61% |
Volatility
MEDP vs. DLB - Volatility Comparison
Medpace Holdings, Inc. (MEDP) has a higher volatility of 6.83% compared to Dolby Laboratories, Inc. (DLB) at 6.02%. This indicates that MEDP's price experiences larger fluctuations and is considered to be riskier than DLB based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| MEDP | DLB | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.83% | 6.02% | +0.81% |
Volatility (6M)Calculated over the trailing 6-month period | 37.78% | 20.37% | +17.41% |
Volatility (1Y)Calculated over the trailing 1-year period | 68.99% | 25.14% | +43.85% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 51.61% | 25.03% | +26.58% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 49.76% | 26.61% | +23.15% |
Dividends
MEDP vs. DLB - Dividend Comparison
MEDP has not paid dividends to shareholders, while DLB's dividend yield for the trailing twelve months is around 2.68%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
DLB Dolby Laboratories, Inc. | 2.68% | 2.10% | 1.57% | 1.29% | 1.45% | 0.96% | 0.91% | 1.15% | 1.08% | 0.94% | 1.11% | 1.25% |
MEDP Medpace Holdings, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
MEDP vs. DLB - Financials Comparison
This section allows you to compare key financial metrics between Medpace Holdings, Inc. and Dolby Laboratories, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
MEDP vs. DLB - Profitability Comparison
MEDP - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Medpace Holdings, Inc. reported a gross profit of 196.33M and revenue of 706.60M. Therefore, the gross margin over that period was 27.8%.
DLB - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Dolby Laboratories, Inc. reported a gross profit of 350.90M and revenue of 395.63M. Therefore, the gross margin over that period was 88.7%.
MEDP - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Medpace Holdings, Inc. reported an operating income of 141.50M and revenue of 706.60M, resulting in an operating margin of 20.0%.
DLB - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Dolby Laboratories, Inc. reported an operating income of 112.95M and revenue of 395.63M, resulting in an operating margin of 28.6%.
MEDP - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Medpace Holdings, Inc. reported a net income of 123.87M and revenue of 706.60M, resulting in a net margin of 17.5%.
DLB - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Dolby Laboratories, Inc. reported a net income of 94.92M and revenue of 395.63M, resulting in a net margin of 24.0%.
Frequently Asked Questions
MEDP and DLB have a correlation of 0.29, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
MEDP has higher volatility (6.83%) compared to DLB (6.02%). In terms of maximum drawdown, MEDP dropped -42.87% vs DLB's -62.19%.
MEDP currently has the higher Sharpe Ratio (0.78 vs -1.14), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for MEDP and DLB
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer